Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Clinical trial NCT01598090 · COMPLETED
Trial details
- NCT number
- NCT01598090
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-14
- Primary completion
- 2015-02-04
- Enrollment
- 881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.